133 related articles for article (PubMed ID: 21384742)
1. Comparative study of serum/plasma glycation and lipid peroxidation of young patients with type 1 diabetes mellitus in relation to glycemic compensation and the occurrence of diabetic complications.
Kostolanska J; Jakus V; Barak L; Stanikova A; Waczulikova I
Bratisl Lek Listy; 2010; 111(11):578-85. PubMed ID: 21384742
[TBL] [Abstract][Full Text] [Related]
2. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
Kostolanská J; Jakus V; Barák L
J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
[TBL] [Abstract][Full Text] [Related]
3. Glycation and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications.
Kostolanská J; Jakus V; Barák L
J Pediatr Endocrinol Metab; 2009 Jul; 22(7):635-43. PubMed ID: 19774845
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of early and advanced glycation in relation to the occurrence of microvascular complications in children and adolescents with type 1 diabetes mellitus.
Kostolanská J; Jakus V; Barák L
Physiol Res; 2009; 58(4):553-561. PubMed ID: 18657005
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus.
Jakuš V; Sándorová E; Kalninová J; Krahulec B
Physiol Res; 2014; 63(3):297-309. PubMed ID: 24564602
[TBL] [Abstract][Full Text] [Related]
6. Circulating TGF-β1, glycation, and oxidation in children with diabetes mellitus type 1.
Jakuš V; Sapák M; Kostolanská J
Exp Diabetes Res; 2012; 2012():510902. PubMed ID: 23049541
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c.
Jakus V; Bauerová K; Michalková D; Cársky J
Diabetes Nutr Metab; 2001 Aug; 14(4):207-11. PubMed ID: 11716290
[TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus.
Kalninova J; Jakus V; Glejtkova M; Kuracka L; Sandorova E
Bratisl Lek Listy; 2014; 115(8):457-68. PubMed ID: 25246279
[TBL] [Abstract][Full Text] [Related]
9. Early Formation of Serum Advanced Glycation End-Products in Children with Type 1 Diabetes Mellitus: Relationship with Glycemic Control.
Jaisson S; Souchon PF; Desmons A; Salmon AS; Delemer B; Gillery P
J Pediatr; 2016 May; 172():56-62. PubMed ID: 26947567
[TBL] [Abstract][Full Text] [Related]
10. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus.
Jakus V; Bauerova K; Michalkova D; Carsky J
Bratisl Lek Listy; 2000; 101(9):484-9. PubMed ID: 11187050
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A
J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.
Berg TJ; Dahl-Jørgensen K; Torjesen PA; Hanssen KF
Diabetes Care; 1997 Jun; 20(6):1006-8. PubMed ID: 9167115
[TBL] [Abstract][Full Text] [Related]
13. Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes.
Helleputte S; Calders P; Rodenbach A; Marlier J; Verroken C; De Backer T; Lapauw B
Cardiovasc Diabetol; 2022 Dec; 21(1):277. PubMed ID: 36494687
[TBL] [Abstract][Full Text] [Related]
14. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
Turk Z; Mesić R; Benko B
Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.
Brunvand L; Heier M; Brunborg C; Hanssen KF; Fugelseth D; Stensaeth KH; Dahl-Jørgensen K; Margeirsdottir HD
BMC Cardiovasc Disord; 2017 May; 17(1):133. PubMed ID: 28545398
[TBL] [Abstract][Full Text] [Related]
17. [Impact of long-term glycemic control on changes of lipid profile in children and adolescents with 1 type diabetes mellitus].
Kostolanská J; Jakus V; Barák L; Staníková A
Vnitr Lek; 2011 Jun; 57(6):533-9. PubMed ID: 21751538
[TBL] [Abstract][Full Text] [Related]
18. Peri-implant conditions and levels of advanced glycation end products among patients with different glycemic control.
Al-Sowygh ZH; Ghani SMA; Sergis K; Vohra F; Akram Z
Clin Implant Dent Relat Res; 2018 Jun; 20(3):345-351. PubMed ID: 29350883
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
[TBL] [Abstract][Full Text] [Related]
20. Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.
Leslie RD; Cohen RM
J Diabetes Sci Technol; 2009 Jul; 3(4):635-43. PubMed ID: 20144305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
